Form D Explorer
Ember LifeSciences, Inc. · CIK 2110315

Report a data issueCitable research briefCompare issuerPrivate research collection

Ember LifeSciences, Inc.

CIK 2110315 · Corporation · Inc. DELAWARE · WESTLAKE VILLAGE, California · Other Technology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
1
Amendments
1
Activity
Mar 3, 2026
through Aug 20, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMar 3, 2026 · DAug 20, 2026 · D/ALater minus earlier
Reported offering amount$50,000,000$50,000,000$0
Reported amount sold$20,941,497$32,166,448$11,224,951
Reported investor count—50—
Reported minimum investment$1$1$0

Earlier SEC source: 0002110315-26-000001 · Later SEC source: 0001814554-26-000157

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Aug 20, 2026

Reported offering amount
$50,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$32,166,448

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)